Summary
Becton, Dickinson and Company (BDX) has filed an 8-K report to announce a significant change in its executive leadership. David V. Elkins, the Executive Vice President and Chief Financial Officer (CFO), has resigned from his position. His resignation is set to be effective on November 9, 2012. In response to Mr. Elkins' departure, the company has appointed Suketu Upadhyay as the interim CFO, also effective November 9, 2012. Mr. Upadhyay, 43, brings a wealth of financial experience to the interim role, having served as BD's Senior Vice President and Controller since November 2011. His prior experience includes roles in international finance at BD and significant financial leadership positions at AstraZeneca and Centocor, Inc. (a former Johnson & Johnson subsidiary). This leadership transition is a key event for investors to monitor.
Key Highlights
- 1Resignation of Chief Financial Officer (CFO), David V. Elkins, effective November 9, 2012.
- 2Appointment of Suketu Upadhyay as interim CFO, effective November 9, 2012.
- 3Suketu Upadhyay previously served as Senior Vice President and Controller for BDX.
- 4Mr. Upadhyay has extensive financial experience, including international finance roles.
- 5Prior to joining BDX, Mr. Upadhyay held senior finance positions at AstraZeneca and Centocor, Inc.